Anti-d (DrugBank: -)
1 disease告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
63 | 特発性血小板減少性紫斑病 | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00128882 (ClinicalTrials.gov) | November 2004 | 8/8/2005 | Treatment of Idiopathic Thrombocytopenic Purpura (ITP) With Subcutaneously Administered Anti-D | Treatment of Idiopathic Thrombocytopenic Purpura in Children With Subcutaneously Administered Anti-D | Idiopathic Thrombocytopenic Purpura | Drug: Anti-D | University of Aarhus | Kjaersgaard, Mimi, M.D. | Completed | 1 Year | 14 Years | Both | 45 | Phase 2 | Denmark |